Literature DB >> 16225786

The HIV infection and immune activation: "to fight and burn".

Victor Appay1, François Boutboul, Brigitte Autran.   

Abstract

Immune activation, a normal immune reaction to pathogens, is now recognized as a major driving force of the CD4 T-cell depletion and immune disorders caused by HIV. By contrast, the natural hosts of its ancestor virus, simian immunodeficiency virus, have adapted to this virus by blocking immune activation and remaining healthy. This review will focus on evidence demonstrating how immune activation associated with HIV infection exhausts immune defenses to HIV as well as the immune system, thus leading to immunosenescence and immunodeficiency, and how treatment can disrupt this vicious and ultimately fatal circle.

Entities:  

Year:  2005        PMID: 16225786     DOI: 10.1007/s11908-005-0050-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  50 in total

1.  Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

Authors:  R P Bucy; R D Hockett; C A Derdeyn; M S Saag; K Squires; M Sillers; R T Mitsuyasu; J M Kilby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

2.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

3.  IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2.

Authors:  Y Adachi; N Oyaizu; S Than; T W McCloskey; S Pahwa
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

Review 4.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

5.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Authors:  Guido Silvestri; Donald L Sodora; Richard A Koup; Mirko Paiardini; Shawn P O'Neil; Harold M McClure; Silvija I Staprans; Mark B Feinberg
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

6.  Early reduction of immune activation in lymphoid tissue following highly active HIV therapy.

Authors:  J Andersson; T E Fehniger; B K Patterson; J Pottage; M Agnoli; P Jones; H Behbahani; A Landay
Journal:  AIDS       Date:  1998-07-30       Impact factor: 4.177

7.  CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells.

Authors:  Alicia Algeciras-Schimnich; Stacey R Vlahakis; Angelina Villasis-Keever; Timothy Gomez; Carrie J Heppelmann; German Bou; Carlos V Paya
Journal:  AIDS       Date:  2002-07-26       Impact factor: 4.177

8.  Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

Authors:  M M Lederman; E Connick; A Landay; D R Kuritzkes; J Spritzler; M St Clair; B L Kotzin; L Fox; M H Chiozzi; J M Leonard; F Rousseau; M Wade; J D Roe; A Martinez; H Kessler
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

9.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis.

Authors:  A Algeciras; D H Dockrell; D H Lynch; C V Paya
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  8 in total

Review 1.  Should antiretroviral therapy be started earlier?

Authors:  Joel E Gallant
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

Review 2.  Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existing and upcoming challenges.

Authors:  S Augustine; R A Bonomo
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-09-09

Review 3.  HIV-associated lipodystrophy: impact of antiretroviral therapy.

Authors:  Giovanni Guaraldi; Chiara Stentarelli; Stefano Zona; Antonella Santoro
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

4.  Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals.

Authors:  David C Lange; David Glidden; Eric A Secemsky; Karen Ordovas; Steven G Deeks; Jeffrey N Martin; Ann F Bolger; Priscilla Y Hsue
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

5.  Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.

Authors:  John C Tilton; Alison J Johnson; Marlise R Luskin; Maura M Manion; Jun Yang; Joseph W Adelsberger; Richard A Lempicki; Claire W Hallahan; Mary McLaughlin; Joann M Mican; Julia A Metcalf; Christiana Iyasere; Mark Connors
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

6.  Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages.

Authors:  Tong-Cui Ma; Run-Hong Zhou; Xu Wang; Jie-Liang Li; Ming Sang; Li Zhou; Ke Zhuang; Wei Hou; De-Yin Guo; Wen-Zhe Ho
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

7.  Effect of Immunomodulating Adjuvant Dzherelo (Immunoxel) in HIV Infected Patients Receiving Standard Antiretroviral Therapy.

Authors:  Lyudmila G Nikolaeva; Tatiana V Maystat; Yuri L Volyanskii; Volodymyr S Pylypchuk; Valery M Frolov; Galyna A Kutsyna
Journal:  Open Virol J       Date:  2009-05-05

8.  Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection.

Authors:  Afam Okoye; Martin Meier-Schellersheim; Jason M Brenchley; Shoko I Hagen; Joshua M Walker; Mukta Rohankhedkar; Richard Lum; John B Edgar; Shannon L Planer; Alfred Legasse; Andrew W Sylwester; Michael Piatak; Jeffrey D Lifson; Vernon C Maino; Donald L Sodora; Daniel C Douek; Michael K Axthelm; Zvi Grossman; Louis J Picker
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.